Biomaterials with multifaceted tunability and bio-specificity. Polyurethanes, a family of polymers with independently tunable mechanical and biodegradation properties, will be developed as a versatile platform material for biomedical implants. Novel energetic ion treatments that allow the coupling of bioactive agents to surfaces will eliminate adverse reactions and enable integration with surrounding tissue.
A novel electrospraying technology platform for controlled and targeted growth factor delivery. This project will develop a new growth factor delivery strategy to stimulate bone regeneration. The project will utilise the technique of electrospraying to create small dissolving polymer microspheres containing bone-relevant growth factors, which are released gradually as the polymer degrades after implantation into a bone defect site to promote healing.
Multifunctional surfaces for implantable biomedical devices. This project aims to improve the quality of life of patients receiving biomedical implants. The project will develop new plasma processing methods to create surfaces for implants that will give control over the response of human tissues. Tissue integration with the device will be achieved where required and infection suppressed.
Polyion complex micelles as smart nano-sized drug carriers for proteins. Novel treatments against diseases are often based on proteins, which are unstable against hydrolysis and sometimes difficult to deliver across the cell membrane. The aim of the project is to create a smart drug carrier that can encapsulate proteins efficiently. A range of block copolymers will be synthesised that are able to condense a positively charged protein resulting in the formation of polyion complex micelles. The po ....Polyion complex micelles as smart nano-sized drug carriers for proteins. Novel treatments against diseases are often based on proteins, which are unstable against hydrolysis and sometimes difficult to deliver across the cell membrane. The aim of the project is to create a smart drug carrier that can encapsulate proteins efficiently. A range of block copolymers will be synthesised that are able to condense a positively charged protein resulting in the formation of polyion complex micelles. The polymer structure will be fine-tuned to create a drug carrier that releases the protein efficiently once inside mammalian cells. The outcome will be the enhanced understanding of the relationship between polymer structure and the activity of the protein and ultimately the design of an advanced and smart drug carrier.Read moreRead less
Clean technologies for the synthesis and purification of a biohybrid and biodegradable polymer. The project aims to transform an Australian industry in the forefront of the global market for manufacturing biodegradable polymers and boost export earnings derived from CO2 based biohybrid polymers. The project will develop cost-effective and clean methods for processing CO2 based polymers and demonstrate its potential for packaging and biomedical applications.
Discovery Early Career Researcher Award - Grant ID: DE130101550
Funder
Australian Research Council
Funding Amount
$375,000.00
Summary
Functional polymer encapsulation to enhance biological performance of implantable materials. This project will develop biomaterial films from essential oils using a low-cost 'green' technology. Applied to commercial biomaterials, these films will minimise infections and inflammations commonly associated with implants. These films will also enable clinical use of metallic resorbable implants for tissue engineering and function restoration.
Nanoporous siloxane membranes for ultrasound mediated ophthalmic drug delivery. This project will develop tailored polymers for use in a novel non-invasive ocular drug delivery device which treats vision threatening conditions such as age-related macular degeneration (AMD). The outcomes of this project will enable an entirely new ocular drug delivery technology, thereby delivering significant benefit to ophthalmic healthcare.
Learning from nature: creating synthetic viruses using self-assembled structures with branched or dendritic glycopolymers on their surfaces. Viruses are nature's clever nanoparticles. Viruses use glycoproteins to find and invade their host cells. This project will aim to mimic nature by generating nanoparticles that carry synthetic glycopolymers on the surface to create better drug delivery carriers.